438 related articles for article (PubMed ID: 15327385)
1. In vivo expression of podocyte slit diaphragm-associated proteins in nephrotic patients with NPHS2 mutation.
Zhang SY; Marlier A; Gribouval O; Gilbert T; Heidet L; Antignac C; Gubler MC
Kidney Int; 2004 Sep; 66(3):945-54. PubMed ID: 15327385
[TBL] [Abstract][Full Text] [Related]
2. The relationship among nephrin, podocin, CD2AP, and alpha-actinin might not be a true 'interaction' in podocyte.
Fan Q; Xing Y; Ding J; Guan N; Zhang J
Kidney Int; 2006 Apr; 69(7):1207-15. PubMed ID: 16501493
[TBL] [Abstract][Full Text] [Related]
3. [A novel mutation of NPHS2 identified in a Chinese family with steroid-resistant nephrotic syndrome].
Yu ZH; Ding J; Guan N; Shi Y; Zhang JJ; Huang JP; Yao Y; Yang JY
Zhonghua Er Ke Za Zhi; 2004 Feb; 42(2):108-12. PubMed ID: 15059485
[TBL] [Abstract][Full Text] [Related]
4. Disease-causing missense mutations in NPHS2 gene alter normal nephrin trafficking to the plasma membrane.
Nishibori Y; Liu L; Hosoyamada M; Endou H; Kudo A; Takenaka H; Higashihara E; Bessho F; Takahashi S; Kershaw D; Ruotsalainen V; Tryggvason K; Khoshnoodi J; Yan K
Kidney Int; 2004 Nov; 66(5):1755-65. PubMed ID: 15496146
[TBL] [Abstract][Full Text] [Related]
5. Podocin, a raft-associated component of the glomerular slit diaphragm, interacts with CD2AP and nephrin.
Schwarz K; Simons M; Reiser J; Saleem MA; Faul C; Kriz W; Shaw AS; Holzman LB; Mundel P
J Clin Invest; 2001 Dec; 108(11):1621-9. PubMed ID: 11733557
[TBL] [Abstract][Full Text] [Related]
6. Molecular basis of steroid-resistant nephrotic syndrome.
Antignac C
Nefrologia; 2005; 25 Suppl 2():25-8. PubMed ID: 16050398
[TBL] [Abstract][Full Text] [Related]
7. [Structure and function of the glomerular filtration barrier].
Musiał K; Zwolińska D
Pol Merkur Lekarski; 2005 Mar; 18(105):317-20. PubMed ID: 15997642
[TBL] [Abstract][Full Text] [Related]
8. Nephrotic plasma alters slit diaphragm-dependent signaling and translocates nephrin, Podocin, and CD2 associated protein in cultured human podocytes.
Coward RJ; Foster RR; Patton D; Ni L; Lennon R; Bates DO; Harper SJ; Mathieson PW; Saleem MA
J Am Soc Nephrol; 2005 Mar; 16(3):629-37. PubMed ID: 15659563
[TBL] [Abstract][Full Text] [Related]
9. Diversities of podocyte molecular changes induced by different antiproteinuria drugs.
Xing Y; Ding J; Fan Q; Guan N
Exp Biol Med (Maywood); 2006 May; 231(5):585-93. PubMed ID: 16636307
[TBL] [Abstract][Full Text] [Related]
10. CD2AP mutations are associated with sporadic nephrotic syndrome and focal segmental glomerulosclerosis (FSGS).
Gigante M; Pontrelli P; Montemurno E; Roca L; Aucella F; Penza R; Caridi G; Ranieri E; Ghiggeri GM; Gesualdo L
Nephrol Dial Transplant; 2009 Jun; 24(6):1858-64. PubMed ID: 19131354
[TBL] [Abstract][Full Text] [Related]
11. Molecular basis of the functional podocin-nephrin complex: mutations in the NPHS2 gene disrupt nephrin targeting to lipid raft microdomains.
Huber TB; Simons M; Hartleben B; Sernetz L; Schmidts M; Gundlach E; Saleem MA; Walz G; Benzing T
Hum Mol Genet; 2003 Dec; 12(24):3397-405. PubMed ID: 14570703
[TBL] [Abstract][Full Text] [Related]
12. Podocin localizes in the kidney to the slit diaphragm area.
Roselli S; Gribouval O; Boute N; Sich M; Benessy F; Attié T; Gubler MC; Antignac C
Am J Pathol; 2002 Jan; 160(1):131-9. PubMed ID: 11786407
[TBL] [Abstract][Full Text] [Related]
13. Analysis of NPHS1, NPHS2, ACTN4, and WT1 in Japanese patients with congenital nephrotic syndrome.
Sako M; Nakanishi K; Obana M; Yata N; Hoshii S; Takahashi S; Wada N; Takahashi Y; Kaku Y; Satomura K; Ikeda M; Honda M; Iijima K; Yoshikawa N
Kidney Int; 2005 Apr; 67(4):1248-55. PubMed ID: 15780077
[TBL] [Abstract][Full Text] [Related]
14. [NPHS2 Mutation analysis study in children with steroid-resistant nephrotic syndrome].
Azocar M; Vega Á; Farfán M; Cano F
Rev Chil Pediatr; 2016; 87(1):31-6. PubMed ID: 26455708
[TBL] [Abstract][Full Text] [Related]
15. Novel NPHS2 variant in patients with familial steroid-resistant nephrotic syndrome with early onset, slow progression and dominant inheritance pattern.
Suvanto M; Patrakka J; Jahnukainen T; Sjöström PM; Nuutinen M; Arikoski P; Kataja J; Kestilä M; Jalanko H
Clin Exp Nephrol; 2017 Aug; 21(4):677-684. PubMed ID: 27573339
[TBL] [Abstract][Full Text] [Related]
16. CD2-associated protein and glomerular disease.
Wolf G; Stahl RA
Lancet; 2003 Nov; 362(9397):1746-8. PubMed ID: 14643126
[TBL] [Abstract][Full Text] [Related]
17. Knockdown of NUP160 inhibits cell proliferation, induces apoptosis, autophagy and cell migration, and alters the expression and localization of podocyte associated molecules in mouse podocytes.
Wang P; Zhao F; Nie X; Liu J; Yu Z
Gene; 2018 Jul; 664():12-21. PubMed ID: 29704630
[TBL] [Abstract][Full Text] [Related]
18. In vivo expression of putative LMX1B targets in nail-patella syndrome kidneys.
Heidet L; Bongers EM; Sich M; Zhang SY; Loirat C; Meyrier A; Broyer M; Landthaler G; Faller B; Sado Y; Knoers NV; Gubler MC
Am J Pathol; 2003 Jul; 163(1):145-55. PubMed ID: 12819019
[TBL] [Abstract][Full Text] [Related]
19. Selective impairment of gene expression and assembly of nephrin in human diabetic nephropathy.
Benigni A; Gagliardini E; Tomasoni S; Abbate M; Ruggenenti P; Kalluri R; Remuzzi G
Kidney Int; 2004 Jun; 65(6):2193-200. PubMed ID: 15149332
[TBL] [Abstract][Full Text] [Related]
20. Genetic kidney diseases disclose the pathogenesis of proteinuria.
Jalanko H; Patrakka J; Tryggvason K; Holmberg C
Ann Med; 2001 Nov; 33(8):526-33. PubMed ID: 11730159
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
